. Yet, the wound healing, recurrence of infection and lower extremity amputation rates are increasing remarkably among diabetic patients 7 . widespread use of antibiotics along with the natural evolution of bacteria has led to a number of multi-drug resistant bacteria (MDRB) 8, 9 . Acquisition of resistance has become one of the major causes of treatment failure. In contrast, none of the antibacterial agents used in clinical trials possessed sufficiently novel modes of action to circumvent extant antibiotic resistance mechanisms 10 .
the emergence of MDRBs in diabetic wounds is less studied in Indian population. we, therefore, enrolled 591 consecutive diabetic patients with lower limb wounds who were hospitalized from January to December 2012 at the Podiatry Center, Amrita Institute of Medical Sciences and Research Center, Kochi, Kerala, India. Deep tissue was collected from the wound bed under sterile precaution in the operation theater; and bacterial culture was tested against 40 antibiotics (e.g. colistin, tigecycline, teicoplanin, clindamycin, meropenem, amoxicillin ciprofloxacin) the population genetics of pathogenic bacteria has been extensively studied to understand the spread of disease and the evolution of virulence and drug resistance. However, little attention has been paid to bacterial carriage populations, which inhabit hosts without producing disease. Perron et al 15 have found that asymptomatic swine from livestock productions frequently carry populations of Salmonella enterica with a broad range of drug-resistant strains and genetic diversity greatly exceeding from that previously described.
Another major mechanism for bacterial resistance to antibiotics is through the acquisition of a plasmid coding for resistance-mediating proteins.Many of the bacteria become resistant to antibiotics through the process of lateral gene transfer, with the newly acquired genes encoding a variety of resistance-mediating proteins 16 . this plasmid-encoded resistance has been observed for virtually all classes of antibiotics and in a wide variety of Gram-positive and Gram-negative organisms; many antibiotics are no longer effective due to such plasmidencoded resistance 16 . the systematic removal of these resistance-mediating plasmids from the bacteria would re-sensitize bacteria to standard antibiotics 16 . Intravenous human immunoglobulin therapy was reported to augment opsonic activity against various drug-resistant bacteria, and being tried for treating severe bacterial infections in immunocompromised patients with impaired serum opsonic capacity 17 . to conclude, an emergence of MDRBs was observed in lower limb wounds of patients with diabetes. Bacteria isolated from wounds were resistant to most of the antibiotics except colistin, vancomycin, linezolid and tegecycline. Further studies are warranted to understand the reasons for antimicrobial resistance; and for reducing the morbidity and mortality related to wound infections caused by MDRBs. 
